Design of Biorelevant Test Setups for the Prediction of Diclofenac In Vivo Features After Oral Administration

[1]  J. Breitkreutz,et al.  Development of a Taste-Masked Orodispersible Film Containing Dimenhydrinate , 2012, Pharmaceutics.

[2]  Dion R. Brocks,et al.  Multiple Peaking Phenomena in Pharmacokinetic Disposition , 2010, Clinical pharmacokinetics.

[3]  N. Fotaki,et al.  Biorelevant Dissolution Methods and Their Applications in In Vitro- In Vivo Correlations for Oral Formulations~!2009-09-14~!2009-11-02~!2010-04-29~! , 2010 .

[4]  S. Klein.  The Use of Biorelevant Dissolution Media to Forecast the In Vivo Performance of a Drug , 2010, The AAPS Journal.

[5]  N. Fotaki,et al.  Biorelevant dissolution methods and their applications in in vitroin vivo correlations for oralformulations , 2010 .

[6]  Jennifer B Dressman,et al.  Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  Yongnan Xu,et al.  Effect of O-acylmenthol and salt formation on the skin permeation of diclofenac acid , 2009, Drug development and industrial pharmacy.

[8]  D. Barends,et al.  Biowaiver monographs for immediate release solid oral dosage forms: diclofenac sodium and diclofenac potassium. , 2009, Journal of pharmaceutical sciences.

[9]  Clive G. Wilson,et al.  Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  Abu T M Serajuddin,et al.  Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.

[11]  E. Nelson.  Comparative dissolution rates of weak acids and their sodium salts. , 2006, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[12]  Lutz Trahms,et al.  Impact of the intragastric location of extended release tablets on food interactions. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[13]  J. Dressman,et al.  Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[14]  Giuseppe Di Fazio,et al.  Diclofenac salts. I. Fractal and thermal analysis of sodium and potassium diclofenac salts. , 2001, Journal of pharmaceutical sciences.

[15]  A. Reiner,et al.  Increased Absorption Rate of Diclofenac from Fast Acting Formulations Containing Its Potassium Salt , 2001, Arzneimittelforschung.

[16]  E. Meštrović,et al.  Thermal behaviour of diclofenac sodium: decomposition and melting characteristics. , 2001, Chemical & pharmaceutical bulletin.

[17]  Clive G. Wilson,et al.  Physiological Pharmaceutics: Barriers to Drug Absorption , 2000 .

[18]  B. Terhaag,et al.  Bioavailability of a new effervescent tablet of diclofenac. , 2000, International journal of clinical pharmacology and therapeutics.

[19]  K. Peh,et al.  Effect of carbopol and polyvinylpyrrolidone on the mechanical, rheological, and release properties of bioadhesive polyethylene glycol gels , 2000, AAPS PharmSciTech.

[20]  A. Sunshine,et al.  ONSET AND DURATION OF ANALGESIA OF DICLOFENAC POTASSIUM IN THE TREATMENT OF POSTEPISIOTOMY PAIN , 1997, American journal of therapeutics.

[21]  I. Mahmood.  Pharmacokinetic Analysis of the Absorption Characteristics of Diclofenac Sodium in Man by use of a Multi‐segment Absorption Model , 1996, The Journal of pharmacy and pharmacology.

[22]  K. Tabata,et al.  Local absorption kinetics into the portal system using the portal-venous concentration difference after an oral dose of diclofenac in the awakening rat. Accelerative effect of bile on intestinal absorption of diclofenac. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[23]  A. Carcas,et al.  Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks. , 1995, International journal of clinical pharmacology and therapeutics.

[24]  I. Wilding,et al.  In Vivo Evaluation of Enteric-Coated Naproxen Tablets Using Gamma Scintigraphy , 1992, Pharmaceutical Research.

[25]  V. John,et al.  Application of Radiotelemetric Technique in Evaluating Diclofenac Sodium Absorption After Oral Administration of Various Dosage Forms in Healthy Volunteers , 1990, Pharmaceutical Research.

[26]  M. Rongier,et al.  Evaluation of the gastric absorption and emptying of drugs under various pH conditions using a simple intubation method: application to diclofenac. , 1989, British journal of clinical pharmacology.

[27]  Clive G. Wilson,et al.  Bimodal release of ibuprofen in a sustained-release formulation: a scintigraphic and pharmacokinetic open study in healthy volunteers under different conditions of food intake , 1989 .

[28]  Gordon L. Amidon,et al.  The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon , 1987, Journal of Pharmacokinetics and Biopharmaceutics.

[29]  S. Davis,et al.  Alimentary tract andpancreas Transit ofpharmaceutical dosage forms through the , 1986 .

[30]  A. Sallmann.  The history of diclofenac. , 1985, Seminars in arthritis and rheumatism.

[31]  Paul Kippax,et al.  Appraisal of the laser diffraction particle-sizing technique , 2005 .

[32]  Nai-ning Song,et al.  Overview of factors affecting oral drug absorption , 2004 .

[33]  J. Lötsch,et al.  Population Pharmacokinetics of Fast Release Oral Diclofenac in Healthy Volunteers: Relation to Pharmacodynamics in an Experimental Pain Model , 2004, Pharmaceutical Research.

[34]  Christos Reppas,et al.  Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.

[35]  Haas,et al.  A New Method of Characterizing the Buccal Dissolution of Drugs , 2002 .

[36]  Clive G. Wilson,et al.  Drug Delivery to the Oral Cavity or Mouth , 2000 .

[37]  C. M. Adeyeye,et al.  [analytical profiles of drug substances] volume 19 || diclofenac sodium , 1990 .

[38]  K. Florey,et al.  Analytical profiles of drug substances , 1972 .